# Ahsan Alam

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ahsan-alam/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,955 |
| Field | Genetic and Kidney Cyst Diseases |
| h-index | 23 |
| i10-index | 38 |
| Last Known Institution | Borgess Health |
| OpenAlex ID | https://openalex.org/A5101893063 |
| ORCID iD | 0009-0000-4128-6285 |
| Works | 97 |

## Researcher papers

Showing 12 of 13.

- [Autosomal dominant polycystic kidney disease](https://scholariq.org/papers/autosomal-dominant-polycystic-kidney-disease-2/)
- [Global Small Bowel Motility: Assessment with Dynamic MR Imaging](https://scholariq.org/papers/global-small-bowel-motility-assessment-with-dynamic-mr-imaging/)
- [The Outcome of Heart Transplant Recipients Following the Development of End-Stage Renal Disease: Analysis of the Canadian Organ Replacement Register (CORR)](https://scholariq.org/papers/the-outcome-of-heart-transplant-recipients-following-the-development-of-end/)
- [Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy](https://scholariq.org/papers/total-kidney-volume-in-autosomal-dominant-polycystic-kidney-disease-a-biomarker/)
- [Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial](https://scholariq.org/papers/initiation-of-continuous-renal-replacement-therapy-versus-intermittent/)
- [Decreased Survival in Liver Transplant Patients Requiring Chronic Dialysis: A Canadian Experience](https://scholariq.org/papers/decreased-survival-in-liver-transplant-patients-requiring-chronic-dialysis-a/)
- [Total Kidney Volume as a Biomarker of Disease Progression in Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/total-kidney-volume-as-a-biomarker-of-disease-progression-in-autosomal-dominant/)
- [Is lower and lower better and better? A re-evaluation of the evidence from the Cholesterol Treatment Trialists’ Collaboration meta-analysis for low-density lipoprotein lowering](https://scholariq.org/papers/is-lower-and-lower-better-and-better-a-re-evaluation-of-the-evidence-from-the/)
- [Management of ESRD in Patients With Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/management-of-esrd-in-patients-with-autosomal-dominant-polycystic-kidney-disease/)
- [Impact of acute kidney injury following liver transplantation on long‐term outcomes](https://scholariq.org/papers/impact-of-acute-kidney-injury-following-liver-transplantation-on-long-term/)
- [Updated Canadian Expert Consensus on Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/updated-canadian-expert-consensus-on-assessing-risk-of-disease-progression-and/)
- [Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/assessing-risk-of-disease-progression-and-pharmacological-management-of/)

## Researcher topics

- [Genetic and Kidney Cyst Diseases](https://scholariq.org/topics/genetic-and-kidney-cyst-diseases/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Organ Donation and Transplantation](https://scholariq.org/topics/organ-donation-and-transplantation/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)

## Researcher university

- [Borgess Health](https://scholariq.org/institutions/borgess-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.